MLL Legal advised owner of Vio Chemicals with regards to the sale of 100% of the shares to KKR-backed Biosynth Group.
Vio Chemicals is specialized in the custom design and production of specialty chemicals, intermediates and Active Pharmaceutical Ingredients (APIs) and supplies the chemical, pharmaceutical, cosmetic and nutrition industries with more than 2,500 products. With its vast network of partners in China and India and experience in processes, customised product design, development and production, Vio Chemicals offers individual, reliable, sustainable, and flexible manufacturing and supply chain solutions.
The Biosynth Group is active as a life science reagents, custom synthesis and manufacturing services company. Its services and products include enzyme development and biocatalysis, reagents for in vitro diagnostics and bioconjugation chemistry. With the integration of Vio Chemicals in the Biosynth Group, the Biosynth Group secures a valuable network and expertise for its key business.
The MLL Legal team was led by Dr. Alexander Vogel (Senior Partner, Corporate/M&A) and consisted of Armin Trautmann (Associate, M&A), Melanie Müller (Senior Associate, Corporate/M&A), Selina Bruderer (Corporate/M&A), Lara Langer (Junior Associate) and Dimitri Rotter (Partner, Tax).